GlassScriptPhysician profile
Nima P Patel
NPI 1417118845
$5,900.15
in general payments reported to CMS, 2019-2025
14 companies · $2,088 in 2025
The $2,088 reported for 2025 was more than what 84% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,370 · 2020: $16.94 · 2021: $102 · 2022: $515 · 2023: $341 · 2024: $467 · 2025: $2,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,466 · Food and Beverage: $858 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $407 · Consulting Fee: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,465.51 |
| Food and Beverage | $858.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $407.00 |
| Consulting Fee | $165.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $3,362.97 | 2019-2025 | |
| Kci USA, INC. | $940.00 | 2019 | |
| Becton, Dickinson and Company | $857.00 | 2022-2024 | Sherlock |
| Medtronic, INC. | $255.00 | 2021-2023 | Straightshot, Lapro-Clip, Surgipro Ll |
| Abbvie INC. | $213.06 | 2023-2025 | |
| Mentor Worldwide LLC | $71.86 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $39.24 | 2020-2021 | |
| Tela Bio, INC. | $38.57 | 2024 | Ovitex 2s |
| Solventum Corporation | $24.45 | 2025 | Activ.A.C. |
| Cook Medical LLC | $23.02 | 2025 | Zenith Alpha |
| Novo Nordisk INC | $21.42 | 2024 | Ozempic, Rybelsus |
| Tei Biosciences INC | $20.11 | 2019 | |
| Allergan, INC. | $18.63 | 2019 | |
| Integra Lifesciences Corporation | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.